Your browser doesn't support javascript.
loading
Resveratrol glucuronidation in vitro: potential implications of inhibition by probenecid.
Matin, Bahar; Sherbini, Ahmad A; Alam, Novera; Harmatz, Jerold S; Greenblatt, David J.
Affiliation
  • Matin B; Graduate Program in Pharmacology and Drug Development, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA, USA.
  • Sherbini AA; Graduate Program in Pharmacology and Drug Development, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA, USA.
  • Alam N; Graduate Program in Pharmacology and Drug Development, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA, USA.
  • Harmatz JS; Graduate Program in Pharmacology and Drug Development, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA, USA.
  • Greenblatt DJ; Graduate Program in Pharmacology and Drug Development, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA, USA.
J Pharm Pharmacol ; 71(3): 371-378, 2019 Mar.
Article in En | MEDLINE | ID: mdl-30417385
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Probenecid / Glucuronides / Resveratrol Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Pharm Pharmacol Year: 2019 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Probenecid / Glucuronides / Resveratrol Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Pharm Pharmacol Year: 2019 Type: Article Affiliation country: United States